Atypical location of metastatic ovarian carcinoma detected by (18)F-FDG PET/CT.
Servicio de Radiología, Hospital Universitario Araba, Vitoria-Gasteiz, Álava, España. Electronic address: jonesagasta@gmail.com.
J
J
Sagasta Urrutia
Servicio de Medicina Nuclear, Hospital Universitario Araba , Vitoria-Gasteiz, Álava, España.
H
H
Portilla-Quattrociocchi
Servicio de Medicina Nuclear, Hospital Universitario Araba , Vitoria-Gasteiz, Álava, España.
D
D
Garcia Hernandez
Servicio de Medicina Nuclear, Hospital Universitario Araba , Vitoria-Gasteiz, Álava, España.
A
A
Montero de la Peña
Servicio de Medicina Nuclear, Hospital Universitario Araba , Vitoria-Gasteiz, Álava, España.
C
C
Moreno Capdevila
Servicio de Medicina Nuclear, Hospital Universitario Araba , Vitoria-Gasteiz, Álava, España.
I
I
Tobalina Larrea
D000368:Aged; D001943:Breast Neoplasms / Q000000981:diagnostic imaging* / Q000556:secondary*; D018283:Cystadenocarcinoma, Papillary / Q000000981:diagnostic imaging* / Q000556:secondary* / Q000628:therapy; D018284:Cystadenocarcinoma, Serous / Q000000981:diagnostic imaging* / Q000556:secondary* / Q000628:therapy; D005260:Female; D005462:Fluorine Radioisotopes / Q000032:analysis / Q000493:pharmacokinetics; D019788:Fluorodeoxyglucose F18 / Q000032:analysis / Q000493:pharmacokinetics; D006801:Humans; D008207:Lymphatic Metastasis / Q000000981:diagnostic imaging; D009367:Neoplasm Staging; D010051:Ovarian Neoplasms / Q000473:pathology* / Q000628:therapy; D010534:Peritoneal Neoplasms / Q000000981:diagnostic imaging / Q000556:secondary; D000072078:Positron Emission Tomography Computed Tomography; D019275:Radiopharmaceuticals / Q000032:analysis / Q000493:pharmacokinetics
D005462:Fluorine Radioisotopes; D019275:Radiopharmaceuticals; D019788:Fluorodeoxyglucose F18